Invention Grant
US09174951B2 Glucose transporter inhibitors 有权
葡萄糖转运蛋白抑制剂

Glucose transporter inhibitors
Abstract:
Thiazolidinedione compounds and pharmaceutically acceptable salts thereof are described. The compounds can be used in methods of treating cancer in a subject by administering to the subject a therapeutically effective amount of the compound. The compounds can also be used in methods of inhibiting glucose uptake in a cell by contacting the cell with the compound.
Public/Granted literature
Information query
Patent Agency Ranking
0/0